CME.NASDAQCme Group INC

DEF: CME Group Reports Record 2025 Performance, Proposes Governance Overhaul

Sentiment:

Proxy Statement


CME Group achieved its most successful year in 2025 with record revenue and trading volumes, while proposing significant corporate governance changes to eliminate Class B director election rights.

Better than expectedRecord average daily volume (ADV) of 28.1 million contracts, up 6% from 2024.Record revenue of $6.5 billion, marking four consecutive years of record revenue.Record adjusted operating income, adjusted net income, and adjusted earnings per share.Total dividends declared for 2025 exceeded $4 billion.Stock price increased by 18% in 2025, with an implied total shareholder return (TSR) of +22%.Cash earnings for the 2025 annual bonus program achieved approximately 114.3% of the target goal.Performance shares for 2023-2025 tied to TSR relative to S&P 500 achieved 200.0% of the target.

Summary

  • 2025 was CME Group's most successful year, marking the fifth straight year of record average daily volume (ADV) at 28.1 million contracts, up 6% from 2024.
  • The company achieved $6.5 billion in revenue, its fourth consecutive year of record revenue, adjusted operating income, adjusted net income, and adjusted earnings per share, with a 6% increase over 2024 revenue.
  • Five out of six asset classes hit annual revenue records.
  • Total dividends declared for 2025 exceeded $4 billion, including an aggregate annual variable dividend of $2.2 billion.
  • Quarterly dividend payments increased by 9% to an annual return of $5.00 per share.
  • International business had a record year, with non-U.S. volume up 8% to 8.4 million contracts daily.
  • Stock price increased by 18% in 2025, with an implied total shareholder return (TSR) of +22% (including dividends).
  • The company purchased approximately $300,000 of Class A common stock under its $3 billion share repurchase program.
  • Shareholders will vote on proposals to eliminate Class B-1, Class B-2, and Class B-3 shareholders' rights to elect directors, offering consideration of $6,200, $4,100, and $2,000 per share, respectively.
  • The board recommends voting FOR these Class B proposals to modernize corporate governance due to consistent low voter participation in Class B director elections.
  • The company is launching clearing services for U.S. Treasuries and Repo markets and expanding cross-margining with FICC.
  • A partnership with FanDuel aims to attract new traders through prediction markets.
  • 24/7 crypto trading will launch in Q2 2026, with new crypto products planned.
  • The company achieved 114.3% of its cash earnings target for the 2025 annual bonus program.
  • Performance shares for 2023-2025 tied to TSR relative to S&P 500 achieved 200.0% of the target.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this filing as overwhelmingly positive, reflecting record financial and operational achievements in 2025 and strategic initiatives for future growth, despite some corporate governance challenges related to Class B shares.

Positives

  • Most successful year in CME Group history in 2025.
  • Fifth straight year of record average daily volume (ADV), climbing 6% to 28.1 million contracts.
  • New records set in interest rates, energy, agriculture, metals, and crypto.
  • Non-U.S. volume increased 8% to a record 8.4 million contracts daily.
  • Record revenue of $6.5 billion, marking four consecutive years of record revenue.
  • Record adjusted operating income of $4.5 billion, up 8% on an adjusted basis.
  • Record net income of $4.1 billion and diluted earnings per common share of $11.16.
  • Record adjusted net income of $4.1 billion, up 9% on an adjusted basis, with adjusted diluted earnings per common share of $11.20, up 9% on an adjusted basis.
  • Five of six asset classes hit annual revenue records.
  • Declared over $4 billion in total dividends for 2025, including an aggregate annual variable dividend of $2.2 billion.
  • 2025 Quarterly dividend payments increased by 9% to an annual return of $5.00 per share.
  • Actual operating margin of 64.9% and 69.4% on an adjusted basis.
  • Provided $80 billion in average daily margin offsets in Q4 2025, approximately $20 billion more than the year before.
  • Stock price increased by 18% in 2025, with an implied total shareholder return (TSR) of +22% (including dividends).
  • Purchased approximately $300,000 of Class A common stock under the $3 billion share repurchase program.
  • Significant year-over-year growth in recently launched products: 32% growth in Micro products and 11% growth in OTC alternative products.
  • Extended exclusive NASDAQ 100 license through 2039 and FTSE/Russell license through 2037.
  • Received approval to operate a Securities Clearing Agency to support compliance with upcoming U.S. Treasury clearing requirements.
  • Expanded retail footprint through event contracts and partnership with FanDuel, reaching 12 million U.S. users.
  • Launched CME FX Spot+ and BrokerTec Chicago, and enhanced analytics for volatility traders.
  • 2025 employee engagement survey had an overall engagement score of 82%.
  • Cash earnings for 2025 annual bonus program achieved approximately 114.3% of the target goal.
  • Performance shares for 2023-2025 tied to TSR relative to S&P 500 achieved 200.0% of the target.

Negatives

  • Consistent low voter participation in Class B director elections (below 25% over the past three years), preventing valid elections since 2020 for Class B-1, 2022 for Class B-2, and 2018 for Class B-3.
  • Uncertainty around Class B election quorums is hindering board evaluation, nomination, and refreshment processes.

Risks

  • Increasing competition by foreign and domestic entities, including new entrants and consolidation.
  • Ability to keep pace with rapid technological developments, including completing cloud migration while maintaining reliability and security.
  • Ability to introduce innovative and competitive new products and services on a timely, cost-effective basis.
  • Ability to adjust fixed costs and expenses if revenues decline.
  • Ability to manage variable costs associated with Google Cloud transition and minimize duplicative costs.
  • Resilience of electronic platforms and soundness of business continuity/disaster recovery plans, including cyberattacks and supplier disruptions.
  • Ability to maintain existing customers, develop strategic relationships, and attract new customers.
  • Ability to expand and globally offer products and services.
  • Changes in regulations, including increased financial/operational resources, tariffs, tax policy changes, restrictions on offerings, or changes in underlying product flows.
  • Costs associated with protecting intellectual property rights and avoiding infringement.
  • Decreases in revenue from market data due to decreased demand or regulatory changes.
  • Changes in rate per contract due to shifts in product mix, the trading venue, and the mix of customers.
  • Adequacy of credit and liquidity risk management practices to protect from clearing firm/counterparty credit risks and satisfy margin/liquidity requirements for BrokerTec.
  • Effectiveness of compliance and risk management programs, including preventing errors/misconduct and protecting infrastructure against security breaches/IP misappropriation.
  • Dependence on third-party providers and exposure to risks from them.
  • Reliance on third-party distribution partners and potential impacts from changes in their business models.
  • Volatility in commodity, equity, and fixed income prices, and price volatility of financial benchmarks.
  • Economic, social, political, and market conditions, including capital/credit market volatility and impact on customer trading activity.
  • Ability to accommodate increases in contract volume and market data/order transaction traffic and implement enhancements without system degradation.
  • Ability to execute growth strategy and maintain growth effectively.
  • Ability to manage risks, control costs, and achieve synergies from acquisitions, investments, alliances, and joint ventures.
  • Variances in earnings on cash accounts and collateral held by the clearing house.
  • Impact of CME Group pricing/fee level and structure and incentive changes.
  • Impact of aggregation services and internalization on trade flow and volumes.
  • Negative financial impacts from changes to intellectual property and index rights terms.
  • Ability to generate funds and/or manage indebtedness to invest in the business.
  • Industry, channel partner, and customer consolidation and/or concentration.
  • Decreases in trading and clearing activity.
  • Imposition of a transaction tax or user fee on futures/options and/or repeal of the 60/40 tax treatment.
  • Increases in effective tax rates, borrowing costs, or changes in tax policy.
  • Ability to maintain brand and reputation.
  • Unfavorable resolution of material legal proceedings.

Future Outlook

Market uncertainty is expected to continue in 2026, and global investors will need to precisely navigate those conditions. CME Group aims to provide unparalleled risk management products and services, along with unmatched efficiencies, to address these needs. The company plans to launch 24/7 crypto trading in Q2 2026 and add new products to its crypto complex. Clearing services for U.S. Treasuries and Repo markets are expected to launch later in 2026.

Management Comments

  • "2025 was the most successful year in CME Group history."
  • "Amid geopolitical chaos, monetary policy shifts, record government borrowing and inflationary pressures, clients turned to our futures, options, cash markets, data and other products to navigate extreme uncertainty."
  • "These strong performance numbers only tell part of the story. What also matters is the value we deliver to our clients every single day."
  • "Providing unparalleled risk management products and services, along with unmatched efficiencies, is what CME Group does best."

Industry Context

StockSavvy.ai notes that CME Group's record performance in 2025, particularly in derivatives and international markets, underscores its resilience and critical role amidst global economic volatility and geopolitical shifts. The expansion into U.S. Treasuries and Repo clearing services positions the company to capitalize on evolving regulatory requirements and market demand for capital efficiencies, a trend seen across major financial infrastructure providers. The strategic partnership with FanDuel and focus on Micro products and 24/7 crypto trading reflects a proactive approach to attracting a new generation of retail traders and expanding into high-growth, digitally-native asset classes, aligning with broader industry efforts to democratize access to financial markets and embrace digital transformation.

Comparison to Industry Standards

  • CME Group's 2025 stock price increase of 18% and total shareholder return (TSR) of +22% (including dividends) compares favorably to the S&P 500, as evidenced by the 200.0% payout on performance shares tied to relative TSR for the 2023-2025 period.
  • The company's executive compensation peer group includes CBOE Global Markets Inc., Invesco Ltd., Paychex Inc., Equifax Inc., Mastercard Inc., S&P Global Inc., Fiserv Inc., Moody's Corp., The Charles Schwab Corp., Franklin Resources Inc., Nasdaq Inc., T. Rowe Price Group Inc., Intercontinental Exchange Inc., Northern Trust Corp., and Western Union Co.
  • CME Group was positioned at the 29th percentile of its peer group on revenue and at the 80th percentile on market capitalization in 2025, indicating strong market valuation relative to its revenue size within the selected peer set.
  • The custom peer group for TSR comparison includes Cboe Global Markets Inc., Deutsche Boerse Ag, Intercontinental Exchange Inc., London Stock Exchange Group Plc, and Nasdaq Inc.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Financial OfficerNALynne C. FitzpatrickNovember 6, 2024Promotion to expanded role.
Chief Operating OfficerNAJulie Holzrichter SpragueNAAssumed role in addition to leading Clearing House.
Senior Managing Director, Global Head of Fixed IncomeNAMichael DennisAugust 2024Transitioned from Class B director to senior leadership role.
Board MemberNANAMay 2025Three individuals retired, reducing board size.
Independent Lead DirectorDennis A. SuskindCharles P. CareyMay 2025Appointment.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionProposal to eliminate the right of Class B-1 shareholders to elect three directors, offering $6,200 per share.Post-2026 Annual Meeting (if approved)Aims to modernize corporate governance, address low voter participation, and provide greater board flexibility in composition and size.
Board CompositionProposal to eliminate the right of Class B-2 shareholders to elect two directors, offering $4,100 per share.Post-2026 Annual Meeting (if approved)Aims to modernize corporate governance, address low voter participation, and provide greater board flexibility in composition and size.
Board CompositionProposal to eliminate the right of Class B-3 shareholders to elect one director, offering $2,000 per share.Post-2026 Annual Meeting (if approved)Aims to modernize corporate governance, address low voter participation, and provide greater board flexibility in composition and size.
Bylaws AmendmentProposal to remove inoperative provisions from the certificate of incorporation if Class B election rights are eliminated.Post-2026 Annual Meeting (if approved)Conforming changes to reflect the elimination of Class B director election structure.
Board SizeBoard size reduced by three individuals retiring as of the 2025 annual meeting.May 2025Part of a multi-year refreshment initiative to optimize board size.
Board LeadershipCharles P. Carey appointed as independent Lead Director, succeeding Dennis A. Suskind.May 2025Maintains strong independent board leadership with defined responsibilities.
Equity Award VestingOmnibus Stock Plan amended to move from single trigger to double trigger vesting in the event of a change of control for future awards not already subject to an employment agreement.March 1, 2024Responsive to investor feedback, enhances corporate governance practices related to change-in-control provisions.
Performance MetricsAdded a company-specific performance metric (absolute net income margin measured over a three-year period) to performance share design.September 2023 (for 2024-2026 performance period)Strengthens focus on financial performance management can directly impact.
Performance MetricsAdded a vesting cap to performance shares tied to relative TSR such that payout is capped at 100% of target if absolute TSR for the three-year period is negative.September 2023 (for 2024-2026 performance period)Mitigates excessive payouts in scenarios of negative absolute shareholder returns.

Legal Proceedings

  • "Unforeseen litigation" is a factor that may lead to equitable adjustments to cash earnings performance calculation.
  • "Unfavorable resolution of material legal proceedings" is a potential risk factor affecting performance.

Related Party Transactions

  • Mr. Hobert, a director, owns a majority interest in a member firm that made indirect payments to CME Group exceeding $120,000 in 2025 and participated in incentive programs receiving approximately $662,000.
  • Mr. Shepard, a director, is the owner of a trading firm and a minority investor in another trading firm, both of which made indirect payments to CME Group exceeding $120,000 in 2025.
  • Mr. Tierney, a director, is the owner of a member firm that made indirect payments to CME Group exceeding $120,000 in 2025.
  • An immediate family member of Ms. Cook, a director, was employed in a non-officer position in 2025, receiving approximately $188,000 in compensation and other benefits.
  • Two immediate family members of Mr. Duffy, Chairman and CEO, were employed in non-officer positions in 2025, receiving combined aggregate compensation of approximately $132,000 and other benefits.
  • BlackRock Financial Management, Inc., a subsidiary of BlackRock, Inc. (a >5% shareholder), was paid $550,000 in fees for supporting the Clearing House's liquidity risk management and default management programs in 2025.

Stakeholder Impact

  • Shareholders: Direct positive impact from record financial performance, increased dividends, and share repurchase program. Potential for enhanced long-term value from strategic initiatives and improved corporate governance through Class B proposals. Class B shareholders will receive cash consideration if election rights are eliminated.
  • Employees: Positive impact from investment in talent development, competitive compensation and benefits, and a high employee engagement score (82%).
  • Customers: Benefit from new market efficiencies (e.g., U.S. Treasuries clearing, expanded cross-margining), new products (crypto, Micro products, event contracts), and enhanced risk management tools.
  • Regulators: Proactive engagement with regulators and compliance with evolving regulatory regimes (e.g., U.S. Treasury clearing requirements).
  • Communities: Positive impact through corporate giving programs, CME Group Foundation, and employee volunteer initiatives.

Next Steps

  • Elect 14 Equity directors at the 2026 annual meeting.
  • Ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026.
  • Advisory vote on the compensation of named executive officers.
  • Vote on amendments to the certificate of incorporation to eliminate Class B-1, Class B-2, and Class B-3 director election rights.
  • Elect Class B-1, Class B-2, and Class B-3 directors (if Class B proposals are not approved).
  • Launch 24/7 crypto trading in Q2 2026.
  • Add new products to the crypto complex.
  • Launch clearing services for U.S. Treasuries and Repo markets later in 2026.
  • Continue multi-year board refreshment initiative.
  • Continue to reduce board size over time.
  • Nominating and governance committee to consider board composition based on Class B proposals' results.
  • Develop a pipeline of potential board nominees for future consideration.
  • Board and nominating committee to maintain active dialogue with Mr. Duffy regarding his continued service and leadership transition.

Key Dates

DateDescription
1976Charles P. Carey became a member of the MidAmerica Commodity Exchange.
1977Howard J. Siegel became a member of CME.
1978Charles P. Carey became a member of CBOT. Howard J. Siegel began trading career at Moccatta Metals.
1980Patrick J. Mulchrone became a member of CME.
1981Terrence A. Duffy became a CME member and President of TDA Trading, Inc.
1982Martin J. Gepsman became a member of CBOE.
1983Elizabeth A. Cook became a member of CME.
1985Martin J. Gepsman became an independent floor broker and trader. Patrick W. Maloney became a member of CME.
1988William W. Hobert worked for Cooper-Neff and Associates.
1990Howard J. Siegel sold his ownership interest in a futures commission merchant.
1991Patrick J. Mulchrone served as a member of the CME board.
1994William W. Hobert founded Hobert Trading Inc. Martin J. Gepsman became a director.
1995Terrence A. Duffy became a CME board member.
1997William R. Shepard became a director.
1998William W. Hobert founded WH Trading, LLC. Martin J. Gepsman served as Secretary of the board. Terrence A. Duffy became Vice Chairman of the board of CME.
1999Robert J. Tierney became a member of CBOT.
2000Howard J. Siegel became a director. CME Group's demutualization.
2001CME Group formed (as Chicago Mercantile Exchange Holdings Inc.). Terrence A. Duffy became Vice Chairman of the board of CME Holdings.
2002CME Group became a public company. Terrence A. Duffy became Chairman of the Board of CME and CME Holdings. Ernst & Young LLP became the company's auditor.
2003Charles P. Carey served as Chairman of CBOT. Terrence A. Duffy was appointed to the Federal Retirement Thrift Investment Board (FRTIB). Patrick J. Mulchrone founded Advantage Futures.
2004Terrence A. Duffy was confirmed as Assistant Secretary for financial markets at the U.S. Treasury.
2005Dennis A. Suskind was inducted into the Futures Industry Association Hall of Fame.
2006Terrence A. Duffy became Executive Chairman of CME Group. Timothy S. Bitsberger served as Senior Vice President and Treasurer of Freddie Mac.
2007Charles P. Carey became a director. Bryan T. Durkin became Chief Operating Officer. CME's merger with CBOT.
2008Timothy S. Bitsberger became a director. Dennis A. Suskind became a director. CME Group's acquisition of NYMEX.
2010Timothy S. Bitsberger served as Managing Director, Official Institutions FIG Coverage Group of BNP PNA.
2011Deborah J. Lucas served as the Sloan Distinguished Professor of Finance at MIT Sloan School of Management.
2012Daniel G. Kaye retired from Ernst & Young LLP. Deborah J. Lucas became Director of the MIT Golub Center for Finance and Policy. Robert J. Tierney became a member of CME.
2013Terrence A. Duffy's term on FRTIB ended. Daniel G. Kaye served as Interim CFO and Treasurer of HealthEast Care System. Rahael Seifu was a Corporate Associate at Morrison & Foerster LLP.
2014Bryan T. Durkin became Chief Commercial Officer. Rahael Seifu became Associate Corporate Counsel at Google LLC.
2015Elizabeth A. Cook became a director.
2016Terrence A. Duffy became Chairman and Chief Executive Officer of CME Group. Bryan T. Durkin became President of CME Group.
2017Timothy S. Bitsberger served as Managing Director and Portfolio Specialist at The TCW Group. Patrick J. Mulchrone's service on Standard Bank and Trust board ended.
2018William W. Hobert became a director. Deborah J. Lucas became a director.
2019Daniel G. Kaye became a director. Phyllis M. Lockett became a director. Robert J. Tierney became a director. Terrence A. Duffy received Doctor of Public Service, honoris causa, from Saint Xavier University.
2020Bryan T. Durkin became a director. Patrick W. Maloney became a director. Patrick J. Mulchrone became a director. Rahael Seifu became a director. Robert J. Tierney became a member of NYMEX/COMEX. Harold Ford Jr. became Vice Chairman, Corporate and Institutional Banking at PNC Financial Services Group.
2021Bryan T. Durkin served as an advisor to CEO through September. Terrence A. Duffy embarked on partnership with Google Cloud.
March 1, 2024Omnibus Stock Plan amended for 'double trigger' vesting for future equity awards.
November 6, 2024Lynne C. Fitzpatrick's base salary increased. Terrence A. Duffy's employment agreement most recently amended and restated.
May 2025Charles P. Carey appointed independent Lead Director. Dennis A. Suskind's term as independent Lead Director ended. Board size reduced by three individuals retiring.
September 15, 2025Annual equity awards granted to named executive officers.
December 31, 2025End of fiscal year. All outstanding unvested time-vesting equity awards granted to Terrence A. Duffy became vested.
early 2026Nominating and governance committee made preliminary assessment of director independence. Compensation committee certified performance results for September 2022 performance share awards (2023-2025 performance period).
March 12, 2026Compensation committee certified performance results for 2023-2025 performance shares.
March 15, 2026Deadline for shareholder notice for director nominees (Rule 14a-19) for 2027 annual meeting. 2023-2025 performance shares vested.
March 16, 2026Record date for 2026 annual meeting. Ages of nominees are as of this date. Number of shares outstanding of each class of common stock as of this date.
March 23, 2026Notice of Internet Availability of Proxy Materials made available to shareholders on or around this date.
March 25, 2026Proxy materials made available to shareholders on or around this date.
May 13, 2026Deadline for internet/phone voting for 2026 annual meeting (10:59 p.m. Central Time).
May 14, 20262026 Annual Meeting of Shareholders (10:00 a.m. Central Time).
Q2 2026Launch of 24/7 crypto trading.
later in 2026Expected launch of clearing services for U.S. Treasuries and Repo markets.
December 31, 2026Terrence A. Duffy's employment agreement term ends. All outstanding unvested time-vesting equity awards granted to executive will vest if employed. Performance-based equity awards scheduled to vest will vest or forfeit based on actual performance. Other performance-based awards will vest at target level if executive terminates.
2026-2028Performance period for September 2025 performance share awards (TSR relative to S&P 500 and absolute net income margin).
2027 annual meetingTerm for elected directors will last until this meeting. Class B-1, B-2, B-3 Election Rights will be eliminated if proposals are approved. Class B directors elected in 2026 will hold office until this meeting.
January 14, 2027Earliest date for shareholder notice for 2027 annual meeting (other than Rule 14a-8 proposals).
February 13, 2027Latest date for shareholder notice for 2027 annual meeting (other than Rule 14a-8 proposals).
October 26, 2026Earliest date for proxy access nominations for 2027 annual meeting.
November 25, 2026Latest date for shareholder proposals for inclusion in 2027 proxy statement. Latest date for proxy access nominations for 2027 annual meeting.

Recommendation

strong buy

CME Group's 2025 performance, marked by record revenue, trading volumes, and profitability across multiple asset classes, demonstrates exceptional operational strength and market leadership. The significant increase in dividends and ongoing share repurchase program highlight a strong commitment to shareholder returns. Strategic initiatives in U.S. Treasuries clearing, crypto, and retail market expansion position the company for continued growth. While the Class B governance changes address a structural issue, they are unlikely to negatively impact core operations. The overall financial health and forward-looking strategies suggest a robust investment opportunity.

Keywords

CME Group, Derivatives, Futures, Options, Clearing, Financial Markets, SEC Filing, Proxy Statement, Corporate Governance, Executive Compensation, Risk Management, Trading Volume, Revenue, Dividends, Shareholder Return, Class B Shares, U.S. Treasuries, Crypto Trading, Fintech

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.